CY1121115T1 - Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα - Google Patents

Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα

Info

Publication number
CY1121115T1
CY1121115T1 CY181101189T CY181101189T CY1121115T1 CY 1121115 T1 CY1121115 T1 CY 1121115T1 CY 181101189 T CY181101189 T CY 181101189T CY 181101189 T CY181101189 T CY 181101189T CY 1121115 T1 CY1121115 T1 CY 1121115T1
Authority
CY
Cyprus
Prior art keywords
disease
horses
treatment
siclesonid
field
Prior art date
Application number
CY181101189T
Other languages
Greek (el)
English (en)
Inventor
Balazs Albrecht
Michael Aven
Janine Lamar
Ingo Lang
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47552829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1121115(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of CY1121115T1 publication Critical patent/CY1121115T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
CY181101189T 2012-12-21 2018-11-09 Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα CY1121115T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12199302 2012-12-21
EP13811924.3A EP2934479B1 (en) 2012-12-21 2013-12-18 Ciclesonide for the treatment of airway disease in horses
PCT/EP2013/077265 WO2014096115A1 (en) 2012-12-21 2013-12-18 Ciclesonide for the treatment of airway disease in horses

Publications (1)

Publication Number Publication Date
CY1121115T1 true CY1121115T1 (el) 2019-12-11

Family

ID=47552829

Family Applications (2)

Application Number Title Priority Date Filing Date
CY181101189T CY1121115T1 (el) 2012-12-21 2018-11-09 Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα
CY2020015C CY2020015I2 (el) 2012-12-21 2020-06-29 Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY2020015C CY2020015I2 (el) 2012-12-21 2020-06-29 Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα

Country Status (24)

Country Link
US (4) US20140179651A1 (enExample)
EP (1) EP2934479B1 (enExample)
AR (1) AR094241A1 (enExample)
AU (2) AU2013360691B2 (enExample)
BR (2) BR122016029247A2 (enExample)
CA (1) CA2888428C (enExample)
CY (2) CY1121115T1 (enExample)
DK (1) DK2934479T3 (enExample)
ES (1) ES2693779T3 (enExample)
FR (1) FR20C1026I1 (enExample)
HR (1) HRP20181980T1 (enExample)
HU (1) HUS2000020I1 (enExample)
IN (1) IN2015DN02894A (enExample)
LT (2) LT2934479T (enExample)
MA (1) MA38169B2 (enExample)
MX (1) MX368306B (enExample)
NO (1) NO2020014I1 (enExample)
NZ (1) NZ706573A (enExample)
PL (1) PL2934479T3 (enExample)
PT (1) PT2934479T (enExample)
RS (1) RS57740B1 (enExample)
SI (1) SI2934479T1 (enExample)
WO (1) WO2014096115A1 (enExample)
ZA (1) ZA201502288B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2014001557A (es) 2011-08-12 2014-03-31 Boehringer Ingelheim Vetmed Inhibidores de corrientes funny (if) para utilizar en un metodo de tratamiento y prevencion de la insuficiencia cardiaca en felinos.
MX364652B (es) 2012-12-21 2019-05-03 Boehringer Ingelheim Vetmedica Gmbh Formulacion farmaceutica que comprende ciclesonida.
IN2015DN02894A (enExample) 2012-12-21 2015-09-11 Boehringer Ingelheim Vetmed
KR102618119B1 (ko) 2014-06-18 2023-12-27 베링거잉겔하임베트메디카게엠베하 말의 기도 질환의 치료를 위한 무스카린 길항제 및 이의 병용물
WO2018070819A1 (ko) * 2016-10-14 2018-04-19 제주대학교 산학협력단 시클레소나이드를 포함하는, 암 줄기세포 성장 억제용 조성물
US20230033224A1 (en) * 2020-01-10 2023-02-02 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for ameliorating quality of life (qol) in equines
CN115989032A (zh) 2020-07-31 2023-04-18 化学研究有限公司 用于吸入施用的组合疗法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
AU2003272450A1 (en) 2002-09-13 2004-04-30 C. Steven Smith Novel composition and method for treatment of upper respiratory conditions
JP2006528228A (ja) * 2003-05-22 2006-12-14 アルタナ ファルマ アクチエンゲゼルシャフト サルメテロール及びシクレソニドの組合せ物
US20050020692A1 (en) 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
DK1670482T4 (da) 2003-09-16 2022-08-22 Covis Pharma B V Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070134165A1 (en) 2004-04-20 2007-06-14 Altana Pharma Ag Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient
WO2006003078A1 (en) 2004-06-29 2006-01-12 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising steroids and an anticholinergic
DE102004056579A1 (de) 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
UY30542A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
ES2593428T3 (es) 2009-06-25 2016-12-09 Boehringer Ingelheim Vetmedica Gmbh Inhalador
US7829748B1 (en) * 2009-09-21 2010-11-09 Honeywell International Inc. Process for the manufacture of 1,3,3,3-tetrafluoropropene
US20150202297A1 (en) 2012-07-05 2015-07-23 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose and a ternary component
EA201590019A1 (ru) 2012-07-05 2015-09-30 Арвен Айлак Санайи Ве Тиджарет А.С. Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы
US9539408B2 (en) 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
MX364652B (es) 2012-12-21 2019-05-03 Boehringer Ingelheim Vetmedica Gmbh Formulacion farmaceutica que comprende ciclesonida.
IN2015DN02894A (enExample) 2012-12-21 2015-09-11 Boehringer Ingelheim Vetmed
PL3035885T3 (pl) 2013-08-20 2020-06-29 Boehringer Ingelheim Vetmedica Gmbh Inhalator
HRP20201987T1 (hr) 2013-08-20 2021-02-05 Boehringer Ingelheim Vetmedica Gmbh Inhalator
KR102618119B1 (ko) 2014-06-18 2023-12-27 베링거잉겔하임베트메디카게엠베하 말의 기도 질환의 치료를 위한 무스카린 길항제 및 이의 병용물

Also Published As

Publication number Publication date
WO2014096115A1 (en) 2014-06-26
EP2934479A1 (en) 2015-10-28
LTPA2020511I1 (lt) 2020-07-27
IN2015DN02894A (enExample) 2015-09-11
CA2888428C (en) 2021-07-13
AU2013360691A1 (en) 2015-04-16
AR094241A1 (es) 2015-07-22
ES2693779T3 (es) 2018-12-13
BR112015010842A8 (pt) 2019-10-01
PT2934479T (pt) 2018-12-20
US20150313918A1 (en) 2015-11-05
BR122016029247A2 (pt) 2019-08-20
CA2888428A1 (en) 2014-06-26
NO2020014I1 (no) 2020-06-12
MA38169B2 (fr) 2021-08-31
DK2934479T3 (en) 2018-11-05
ZA201502288B (en) 2019-09-25
HRP20181980T1 (hr) 2019-01-25
US20180153907A1 (en) 2018-06-07
FR20C1026I1 (fr) 2020-10-02
CY2020015I1 (el) 2020-11-25
BR112015010842B1 (pt) 2021-03-30
MX2015007947A (es) 2015-10-08
MA38169A1 (fr) 2017-01-31
PL2934479T3 (pl) 2019-02-28
AU2018201642B2 (en) 2019-01-31
AU2013360691B2 (en) 2018-03-08
US20140179651A1 (en) 2014-06-26
AU2018201642A1 (en) 2018-03-29
EP2934479B1 (en) 2018-09-19
US20170079988A1 (en) 2017-03-23
RS57740B1 (sr) 2018-12-31
CY2020015I2 (el) 2021-03-12
NZ706573A (en) 2019-11-29
LT2934479T (lt) 2018-12-27
MX368306B (es) 2019-09-27
HUS2000020I1 (hu) 2020-07-28
SI2934479T1 (sl) 2019-01-31
US10258634B2 (en) 2019-04-16
BR112015010842A2 (pt) 2017-07-11
US9918995B2 (en) 2018-03-20
US10441597B2 (en) 2019-10-15

Similar Documents

Publication Publication Date Title
CY1121115T1 (el) Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα
CY1116315T1 (el) Παραγωγα κιναζολιν-4(3η)-ονης που χρησιμοποιουνται ως αναστολεις κινασης ρι3
CY1123476T1 (el) Τροποποιητες πυρηνικης μεταφορας και χρησεις αυτων
CY1119123T1 (el) Δις-αρυλοσυζευγμενες αρυλοτριαζολονες και η χρηση τους
CY1124000T1 (el) Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες σε κρυσταλλικη μορφη
CY1121150T1 (el) Νευροδραστικα 19-αλκοξυ-17-υποκατεστημενα στεροειδη, χρησιμα σε μεθοδους θεραπειας
CY1122335T1 (el) Μουσκαρινικοι ανταγωνιστες και συνδυασμοι τους για τη θεραπευτικη αντιμετωπιση της νοσου των αναπνευστικων οδων στα αλογα
CY2020032I2 (el) Παραγωγα πλευρομουτιλινης για τη θεραπεια ασθενειων που προκαλουνται απο μικροβια
CY1123485T1 (el) Συνθεσεις και μεθοδοι για τη θεραπεια νοσων
CY1123391T1 (el) (2s)-n-[(1s)-1-kyano-2-φainyλaιθyλ]-1,4-oξazeπan-2-καρβοξαμιδια ως αναστολεις της διπεπτιδυλικης πεπτιδασης ι
CY1120429T1 (el) Παραγωγα κιναζολινης για τη θεραπευτικη αντιμετωπιση ιογενων λοιμωξεων και αλλων νοσων
CY1122292T1 (el) Ενωσεις και μεθοδοι για αντιϊικη αγωγη
CY1120939T1 (el) Συνδυασμος ρεγοραφενιμπης και ακετυλοσαλικυλικου οξεος για τη θεραπευτικη αντιμετωπιση του ορθοκολικου καρκινου
CY1116057T1 (el) Παραγωγα κιναζολιν-4(3η)-ονης που χρησιμοποιουνται ως αναστολεις κινασης ρι3
CY1122730T1 (el) 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων
CY1117372T1 (el) Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες και η χρηση τους
HUE053113T2 (hu) Bardoxolon-metil 2,2-difluorpropionamid-származéka, annak gyógyszerkészítményei és polimorfjai bizonyos betegségek kezelésében történõ alkalmazásra
CY1121736T1 (el) Άλατα aramchol
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
CY1112813T1 (el) 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων
EA201400521A1 (ru) Гетероциклические соединения, лекарственные средства, содержащие указанные соединения, их применение и способы их получения
CY1122115T1 (el) Παραγωγα ν1-ακυλο-5-φθοροπυριμιδινονης
WO2014151456A3 (en) Treatment of inflammatory diseases
HRP20190573T1 (hr) Piranokromenil fenol derivat, i farmaceutska kompozicija za liječenje metaboličkog sindroma ili inflamatorne bolesti
CY1119108T1 (el) Τηγμενα πυρρολοδικαρβοξαμιδια και η χρηση τους ως φαρμακευτικα προϊοντα